05:00 AM EST, 02/06/2025 (MT Newswires) -- AstraZeneca ( AZN ) reported Q4 earnings Thursday of $0.97 per share, up from $0.62 a year earlier.

Analysts polled by FactSet expected $1.76.

Revenue for the quarter ended Dec. 31 was $14.89 billion, compared with $12.02 billion a year earlier.

Analysts polled by FactSet expected $14.23 billion.

The company said it expected 2025 core earnings per share to increase by a low double-digit percentage. Analysts polled by FactSet expect $9.20.

AstraZeneca ( AZN ) also expects revenue growth of a high single-digit percentage for the year. Analysts polled by FactSet expect $56.76 billion.